Dr. Jeremy M. Levin is a physician-scientist and biotech leader who serves as the executive chairman of Ovid Therapeutics, former CEO of Teva Pharmaceuticals, and past chairman of the Biotechnology Innovation Organization (BIO).
Topics
Appearances (1)
- Dr. Jeremy Levin: Why Biotech Is Not Big Pharma
In the Health Policy Podcast episode featuring Dr. Jeremy Levin, founder of Ovid Therapeutics, he discusses the distinction between biotechnology and big pharmaceutical companies. Dr. Levin emphasizes the critical role of biotech in drug innovation, noting that 70% of new drugs originate from this sector. He also addresses the growing distrust in the industry, attributing it to factors like politicization and misinformation, and advocates for biotech to be recognized as a national strategic asset to restore public confidence.
Notable quotes
“70% of the new drugs come from biotech.”
“Distrust starts to creep. And that is where the real problem starts for the industry.”
“We need to make biotech a national strategic asset, just like housing, just like defense.”
“If we don't, none of the things that I've just talked about, the building of science, the establishment of a rigorous world-class FDA, will ever be put into place.”
“Fifty percent of all people taking drugs stop them at the end of the first year.”
“We have commitments. If we do those, they respond to, one, transparency; two, articulating genuine commitment to patients.”
